Source: Betakit

Valence: American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence

"Policymakers should look to understand why so many promising tech companies choose to sell themselves."The post American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence first appeared on BetaKit.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Daniel Cohen's photo - Co-Founder & CEO of Valence

Co-Founder & CEO

Daniel Cohen

CEO Approval Rating

86/100